Burden of Heart Failure After Hospitalization for Myocardial Infarction in the United States: A Targeted Literature Review

Author(s)

Bjornson AM1, Guo K2, Nagase F1, Woodward ML1, Wong AC3, Szabo S1, Bengtson LG3
1Broadstreet HEOR, Vancouver, BC, Canada, 2Boehringer Ingelheim Pharmaceuticals, Inc., Fairfield, NJ, USA, 3Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA

OBJECTIVES: Heart failure (HF) is a common complication after myocardial infarction (MI). However, a synthesis of contemporary evidence on the burden following MI is lacking. A targeted literature review was performed to summarize rates of HF-related admission and mortality, and direct costs for HF admissions after MI in the US.

METHODS: Data from original articles (identified using MEDLINE; January 2018-May 2023), and ACC proceedings (2022, 2023), were tabulated and a gap analysis performed. Due to the breadth of identified literature, this summary focuses on publications that included a generalizable sample of patients with MI, without restricting to a particular subgroup of the MI population.

RESULTS: From 2,665 records, 11 studies presented HF admissions rates after MI; rates at 30 days, 6 months, and 1 year after MI ranged from 0.7%-2.9%, 1.3%-6.9%, and 1.4-9.1%, respectively. Earlier study period, and female patient sex, older age, Black race, or presence of other cardiovascular complications and comorbidities (hypertension, diabetes, and kidney disease) were associated with elevated HF admission rates after MI. Four studies reported on HF-related mortality after MI. Among patients with MI (without cardiogenic shock) who were admitted for HF within 6 months, 4.6% died during HF admission. In another study, 17% of patients with incident MI experienced HF hospitalization after MI hospitalization or death from HF over the median follow-up of 3 years. Renal disease and Black race were significant risk factors for HF-related mortality after MI. No data on the cost of HF admissions after MI were identified.

CONCLUSIONS: HF is a common cause of admission after MI in the US. There is a gap in the literature regarding HF-related mortality and the cost of HF admissions after MI. The identified studies highlight the extent of the burden and need for interventions to reduce the risk of HF after MI.

Conference/Value in Health Info

2024-05, ISPOR 2024, Atlanta, GA, USA

Value in Health, Volume 27, Issue 6, S1 (June 2024)

Code

EPH213

Topic

Epidemiology & Public Health, Health Policy & Regulatory, Real World Data & Information Systems

Topic Subcategory

Health & Insurance Records Systems, Health Disparities & Equity

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×